Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.86p
   
  • Change Today:
    -0.14p
  • 52 Week High: 5.90
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 4,726,668
  • Market Cap: £14.27m
  • RiskGrade: 328
  • Beta: 0.03

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £42,496
Lisa Baderoon 583,963 £16,672
Tim Franklin 525,000 £14,989

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 80,590,404 £2,300,856
Luca & Associates AG 22,000,000 £628,100
Invesco Ltd 17,872,341 £510,255
Aviva Investors Global 11,285,180 £322,192
Alora Pharmaceuticals LLC 10,909,091 £311,454
M&G Investments 7,600,000 £216,980
Prudential plc 7,600,000 £216,980
Capital Income Builder 4,870,367 £139,049
Dr R Zimmer 4,551,553 £129,947
Odey Asset Management 3,433,319 £98,021
Rhone Trustees (Switzerland) SA 3,386,000 £96,670
Pictet Overseas Trust Corporation Limited 3,287,500 £93,858

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.86p
Change Today -0.14p
% Change -4.67 %
52 Week High 5.90
52 Week Low 1.09
Volume 4,726,668
Shares Issued 499.72m
Market Cap £14.27m
Beta 0.03
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.46% below the market average29.46% below the market average29.46% below the market average29.46% below the market average29.46% below the market average
6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average
Price Trend
67.17% above the market average67.17% above the market average67.17% above the market average67.17% above the market average67.17% above the market average
87.23% above the sector average87.23% above the sector average87.23% above the sector average87.23% above the sector average87.23% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 20-May-2025

Time Volume / Share Price
15:57 250,000 @ 2.74p
16:24 100,000 @ 2.85p
16:17 74,356 @ 2.70p
16:10 44,388 @ 2.79p
16:08 110,874 @ 2.79p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page